Your browser doesn't support javascript.
loading
Recommendations and feedback from the European Bioanalysis Forum Workshop: 1 year into ICH M10 - keeping our finger on the pulse.
Timmerman, Philip; Barfield, Matthew; Portabella, Enric Bertran; Calogero, Salvatore; Cowan, Kyra; Faber, Jörg; Ferrari, Luca; Golob, Michaela; Goodman, Jo; Goodwin, Lee; Gnoth, Mark Jean; Hughes, Richard; Ivanova, Tsvetelina; Jordan, Gregor; Laurén, Anna; Maux, Delphine; McDougall, Stuart; Milushewa, Petya; Nelson, Robert; Pynaert, Gwenda; Sklodowski, Kamil; Sleigh, Rebecca; Struwe, Petra; Verhaeghe, Tom; Wheller, Robert; White, Steve; Zeiser, Katja.
Afiliação
  • Timmerman P; European Bioanalysis Forum, Havenlaan 86c b204, Brussels, 1000, Belgium.
  • Barfield M; Roche Innovation Center Welwyn, Roche Pharma Research & Early Development, Welwyn Garden City, Hertfordshire, AL7 1TW, United Kingdom.
  • Portabella EB; Moderna Innovation & Technology Center, Harwell Science & Innovation Campus. Oxford, OX11 0DF, United Kingdom.
  • Calogero S; Swiss BioQuant, Biochemical Analysis, Reinach (BL), 4153, Switzerland.
  • Cowan K; Merck KGaA, Research & Development, Drug Metabolism & Pharmacokinetics New Biological Entities, Darmstadt, 64293, Germany.
  • Faber J; A&M Labor für Analytik und Metabolismusforschung Service GmbH, Bergheim, 50126, Germany.
  • Ferrari L; Roche Pharma Research & Early Development (pRED), F. Hoffmann-La Roche Ltd, Basel, 4070, Switzerland.
  • Golob M; Nuvisan GmbH, Bioanalysis, Neu-Ulm, 89231, Germany.
  • Goodman J; AstraZeneca, Integrated Bioanalysis, Clinical Pharmacology & Safety Sciences, BioPharmaceuticals R&D, Cambridge, CB21 6GH, United Kingdom.
  • Goodwin L; Labcorp, Bioanalytical Services, Otley Road, Harrogate, HG3 1PY, United Kingdom.
  • Gnoth MJ; Bayer, DMPK, in vivo PK & bioanalytics, Bayer AG, Wuppertal, 42096, Germany.
  • Hughes R; Resolian Bioanalytics, Newmarket Road, Fordham, CB7 5WW, United Kingdom.
  • Ivanova T; Quality & Compliance, Comac Medical, Sofia, 1404, Bulgaria.
  • Jordan G; Roche Pharma Research & Early Development (pRED), Pharmaceutical Sciences, Bioanalytics & Biomarkers, Roche Innovation Center Munich, Roche Diagnostics GmbH, Penzberg, 82377, Germany.
  • Laurén A; MinervaX, Lund, 223 63, Sweden (employed by at the time of writing of this manuscript: Novo Nordisk A/S, Non-clinical & Clinical Assay Sciences, Global Discovery & Development Sciences, Global Drug Discovery, Maaløv, DK-2760, Denmark).
  • Maux D; Syneos Health, Clinical Pharmacology & Bioanalysis, Bioanalysis, Biot, 06410, France.
  • McDougall S; Quotient Sciences, Bioanalytical Services, Taylor Drive, Alnwick, Northumberland, NE66 2DH, United Kingdom.
  • Milushewa P; Quality & Compliance, Comac Medical, Sofia, 1404, Bulgaria.
  • Nelson R; BioAgilytix Laboratories, Hamburg, 22339, Germany.
  • Pynaert G; Argenx BV, Bioanalytics, Zwijnaarde, 9052, Belgium.
  • Sklodowski K; Roche Pharma Research & Early Development (pRED), F. Hoffmann-La Roche Ltd, Basel, 4070, Switzerland.
  • Sleigh R; Resolian Bioanalytics, Newmarket Road, Fordham, CB7 5WW, United Kingdom.
  • Struwe P; Celerion Switzerland AG, Bioanalytical Services, Allmendstrasse, Fehraltorf, 8320, Switzerland.
  • Verhaeghe T; J&J Innovative Medicine, BDDS, Beerse, 2340, Belgium.
  • Wheller R; Resolian Bioanalytics, Newmarket Road, Fordham, CB7 5WW, United Kingdom.
  • White S; GSK, IVIVT-BIB, Gunnells Wood Road, Stevenage, SG1 2NY, United Kingdom.
  • Zeiser K; Nuvisan GmbH, Bioanalysis, Neu-Ulm, 89231, Germany.
Bioanalysis ; 16(5): 259-270, 2024 Mar.
Article em En | MEDLINE | ID: mdl-38315622
ABSTRACT
The ICH M10 guideline on bioanalytical method validation and sample analysis is being adopted since 2023. However, and inevitably, some paragraphs or requirements remain ambiguous and are open for different interpretations. In support of a harmonized interpretation by the industry and health authorities, the European Bioanalysis Forum organized a workshop on 14 November 2023 in Barcelona, Spain, to discuss unclear and/or ambiguous paragraphs which were identified by the European Bioanalysis Forum community and delegates of the workshop prior to the workshop. This manuscript reports back from the workshop with recommendations and aims at continuing an open scientific discussion within the industry and with regulators in support of a science-driven guideline for the bioanalytical community and in line with the ICH mission - that is, achieve greater harmonization worldwide to ensure that safe, effective and high-quality medicines are developed and registered in the most resource-efficient manner.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Projetos de Pesquisa / Relatório de Pesquisa Tipo de estudo: Qualitative_research Idioma: En Revista: Bioanalysis Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Bélgica País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Projetos de Pesquisa / Relatório de Pesquisa Tipo de estudo: Qualitative_research Idioma: En Revista: Bioanalysis Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Bélgica País de publicação: Reino Unido